In short. The planning logic behind injectable aesthetics: facial assessment first, substance classes second, conservative staged dosing, and a review before anything is added.
Key points
- Starting conservatively and reviewing at two to four weeks is the discipline behind natural results.
- An injector can always add a little more; removing too much means dissolving filler or waiting months for an effect to wear off.
- The first session is the beginning of a plan, not the whole plan.
Injectable treatment fails most often at the planning stage, not at the needle. A plan that starts from a photograph of someone else’s face, or from a product rather than a problem, produces the overfilled, expressionless results that give the field a bad name. This article explains how injectable plans are built in Dr. Ke He’s practice at Chongqing West District Hospital.
Assessment comes first
Planning starts with the face at rest and in motion: which lines are dynamic and driven by muscle, which are static and etched into skin, where volume has been lost, and how the proportions of the upper, middle, and lower face relate. Skin quality, medical history, previous treatments, and medications are reviewed, and photographs document the baseline. Only then is any substance discussed.
Substance classes, not brands
Three broad classes cover most injectable work. Botulinum toxin relaxes the muscles that create dynamic lines. Hyaluronic-acid dermal fillers restore volume and refine contour, and can be dissolved if needed. Skin boosters deliver hydration and improve skin quality without changing shape. Each class has a distinct mechanism, duration, and risk profile, and each suits different problems; the choice follows the diagnosis.
Under-treat, then refine
Starting conservatively and reviewing at two to four weeks is the discipline behind natural results. An injector can always add a little more; removing too much means dissolving filler or waiting months for an effect to wear off. The first session is the beginning of a plan, not the whole plan.
Staging and combination
Plans are staged. Muscle relaxation, volume restoration, and skin-quality work are often sequenced across visits rather than stacked into one session, because each treatment’s result informs the next. Combination with laser or energy-based treatment follows the same logic, with intervals that let the skin recover between modalities.
Duration and maintenance, honestly
Every injectable is temporary. Botulinum toxin effects typically last three to four months; hyaluronic-acid fillers persist for months to over a year depending on the product family and placement; skin boosters need repeat courses. A written plan states the expected duration and the review schedule, so maintenance is a decision rather than a surprise.
Risks in the plan, not the footnote
Bruising and swelling are common and brief. The serious risk is vascular occlusion — filler entering or compressing a blood vessel — which can cause skin injury and, in rare cases, visual loss. Conservative volumes, anatomical knowledge, and hospital-based emergency readiness are how that risk is managed, not eliminated.
Tell your injector before treatment if
- You are pregnant or breastfeeding, have a neuromuscular disorder, or take blood-thinning medication.
- You have had previous filler or a previous complication, especially in the same area.
- You have an active skin infection, cold sore, or inflammation near the planned treatment site.
Frequently asked questions
Why start conservatively rather than fully correcting at the first visit?
An injector can always add a little more at review, while removing too much means dissolving the material or waiting months for the effect to wear off. Starting conservatively and reviewing at two to four weeks is the discipline behind results that still look natural.
How long does each injectable class actually last?
Botulinum toxin effects typically last three to four months. Hyaluronic-acid fillers persist for months to over a year depending on the product family and the depth of placement. Skin boosters need repeat courses, because their hydration benefit fades as the material is absorbed.
What is the most serious risk of an injectable treatment?
Vascular occlusion, where filler enters or compresses a blood vessel, can injure the skin it supplies and in rare cases affect vision. Conservative volumes, sound anatomical knowledge and hospital-based emergency readiness are how that risk is managed rather than eliminated.
Risks & Limitations
- Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
- Nodules, lumps or granuloma formation, which may need treatment or dissolution.
- Infection at the injection site.
- Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
- Migration of filler away from the intended area.
- Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
- Bruising and swelling. All injectable results are temporary and maintenance is required.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
- A hard, painful lump that is growing.
- Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable safety information
- American Society of Plastic Surgeons (ASPS) — injectable guidance
- U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
- National Medical Products Administration (NMPA, China) — approved product status
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.